INR 862.05
(-1.95%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 942.79 Million INR | 109.37% |
2022 | 450.29 Million INR | 202.98% |
2021 | 148.62 Million INR | 97877.63% |
2020 | -152 Thousand INR | -6.29% |
2019 | -143 Thousand INR | 99.16% |
2018 | -16.94 Million INR | 31.19% |
2017 | -24.62 Million INR | -162.19% |
2016 | 39.59 Million INR | 169.29% |
2015 | 14.7 Million INR | -69.75% |
2014 | 48.6 Million INR | 19.17% |
2013 | 40.78 Million INR | -2.67% |
2012 | 41.9 Million INR | -12.59% |
2011 | 47.94 Million INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q2 | 502.02 Million INR | 4402.46% |
2023 FY | 942.79 Million INR | 109.37% |
2023 Q4 | 942.79 Million INR | 5096.78% |
2023 Q3 | 18.14 Million INR | -96.39% |
2023 Q1 | 11.15 Million INR | -97.52% |
2022 Q4 | 450.29 Million INR | 1866.71% |
2022 Q1 | 22.89 Million INR | -84.6% |
2022 FY | 450.29 Million INR | 202.98% |
2022 Q2 | 358.46 Million INR | 1465.96% |
2022 Q3 | 22.89 Million INR | -93.61% |
2021 FY | 148.62 Million INR | 97877.63% |
2021 Q3 | 175.33 Million INR | 99721.02% |
2021 Q2 | -176 Thousand INR | 0.0% |
2021 Q4 | 148.62 Million INR | -15.23% |
2020 Q1 | 8.34 Million INR | 5937.76% |
2020 FY | -152 Thousand INR | -6.29% |
2020 Q4 | -152 Thousand INR | -100.44% |
2020 Q3 | 34.66 Million INR | 22611.69% |
2020 Q2 | -154 Thousand INR | -101.84% |
2019 Q4 | -143 Thousand INR | -101.13% |
2019 FY | -143 Thousand INR | 99.16% |
2019 Q3 | 12.7 Million INR | 5343.63% |
2019 Q2 | -242.26 Thousand INR | 0.0% |
2018 FY | -16.94 Million INR | 31.19% |
2018 Q4 | -16.94 Million INR | 0.0% |
2018 Q2 | -19.31 Million INR | 0.0% |
2017 Q2 | -26.11 Million INR | 0.0% |
2017 Q4 | -24.62 Million INR | 0.0% |
2017 FY | -24.62 Million INR | -162.19% |
2016 Q1 | 46.87 Million INR | 0.0% |
2016 FY | 39.59 Million INR | 169.29% |
2016 Q4 | 39.59 Million INR | -36.26% |
2016 Q3 | 62.11 Million INR | 0.0% |
2015 FY | 14.7 Million INR | -69.75% |
2014 FY | 48.6 Million INR | 19.17% |
2013 FY | 40.78 Million INR | -2.67% |
2012 FY | 41.9 Million INR | -12.59% |
2011 FY | 47.94 Million INR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Biocon Limited | 140.18 Billion INR | 99.327% |
Blue Jet Healthcare Limited | -830.93 Million INR | 213.463% |
Concord Biotech Limited | -54.04 Million INR | 1844.47% |
Dishman Carbogen Amcis Limited | 18.99 Billion INR | 95.036% |
Jubilant Ingrevia Limited | 6.6 Billion INR | 85.729% |
Lyka Labs Limited | 527.01 Million INR | -78.895% |
Panacea Biotec Limited | -1.18 Billion INR | 179.568% |
Piramal Pharma Limited | 42.27 Billion INR | 97.77% |
SMS Lifesciences India Limited | 992.31 Million INR | 4.99% |
Supriya Lifescience Limited | -694.68 Million INR | 235.717% |
Syngene International Limited | -83 Million INR | 1235.902% |
TAKE Solutions Limited | 361.37 Million INR | -160.896% |